Short-Term Culture with the Caspase Inhibitor z-VAD.fmk Reduces Beta Cell Apoptosis in Transplanted Islets and Improves the Metabolic Outcome of the Graft

In the initial days after transplantation islets are particularly vulnerable and show increased apoptosis and necrosis. We have studied the effects of caspase inhibition on this early beta cell death in syngeneically transplanted islets. Streptozotocin-diabetic C57BL/6 mice were transplanted with 15...

Full description

Bibliographic Details
Main Authors: Marta Montolio, Noèlia Téllez, Montserrat Biarnés, Joan Soler, Eduard Montanya
Format: Article
Language:English
Published: SAGE Publishing 2005-01-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/000000005783983269
id doaj-bed176a684d74ea4b1ab204aa92f1143
record_format Article
spelling doaj-bed176a684d74ea4b1ab204aa92f11432020-11-25T03:46:05ZengSAGE PublishingCell Transplantation0963-68971555-38922005-01-011410.3727/000000005783983269Short-Term Culture with the Caspase Inhibitor z-VAD.fmk Reduces Beta Cell Apoptosis in Transplanted Islets and Improves the Metabolic Outcome of the GraftMarta Montolio0Noèlia Téllez1Montserrat Biarnés2Joan Soler3Eduard Montanya4Laboratory of Diabetes and Experimental Endocrinology, Endocrine Unit, IDIBELL-Hospital Universitari de Bellvitge, University of Barcelona, Barcelona, SpainLaboratory of Diabetes and Experimental Endocrinology, Endocrine Unit, IDIBELL-Hospital Universitari de Bellvitge, University of Barcelona, Barcelona, SpainLaboratory of Diabetes and Experimental Endocrinology, Endocrine Unit, IDIBELL-Hospital Universitari de Bellvitge, University of Barcelona, Barcelona, SpainLaboratory of Diabetes and Experimental Endocrinology, Endocrine Unit, IDIBELL-Hospital Universitari de Bellvitge, University of Barcelona, Barcelona, SpainLaboratory of Diabetes and Experimental Endocrinology, Endocrine Unit, IDIBELL-Hospital Universitari de Bellvitge, University of Barcelona, Barcelona, SpainIn the initial days after transplantation islets are particularly vulnerable and show increased apoptosis and necrosis. We have studied the effects of caspase inhibition on this early beta cell death in syngeneically transplanted islets. Streptozotocin-diabetic C57BL/6 mice were transplanted with 150 syngeneic islets, an insufficient mass to restore normoglycemia, preincubated with or without the pan-caspase inhibitor z-VAD. fmk 2 h before transplantation. Beta cell apoptosis was increased in control islets on day 3 after transplantation (0.28 ± 0.02%) compared with freshly isolated islets (0.08 ± 0.02%, p< 0.001), and was partially reduced in transplanted islets preincubated with z-VAD.fmk 200 μM (0.14 ± 0.02%, p = 0.003) or with z-VAD.fmk 500 μM (0.17 ± 0.01%, p = 0.012), but not with a lower z-VAD.fmk (100 μM) concentration. Diabetic mice transplanted with islets preincubated with z-VAD.fmk 500 μM showed an improved metabolic evolution compared with control and z-VAD.fmk 200 μM groups. The z-VAD.fmk 500 μM group showed an overall lower blood glucose after transplantation (p = 0.02), and at the end of the study blood glucose values were reduced compared with transplantation day (15.7 ± 3.6 vs. 32.5 ± 0.5 mmol/L, p = 0.001). In contrast, blood glucose was not significantly changed in control and z-VAD.fmk 200 μM groups. Four weeks after transplantation beta cell mass was higher in z-VAD.fmk 500 μM group (0.15 ± 0.02 mg) than in the control group (0.10 ± 0.02 mg) (p = 0.043). In summary, the treatment of freshly isolated islets with the caspase inhibitor z-VAD.fmk reduced the subsequent apoptosis of the islets once they were transplanted and improved the outcome of the graft.https://doi.org/10.3727/000000005783983269
collection DOAJ
language English
format Article
sources DOAJ
author Marta Montolio
Noèlia Téllez
Montserrat Biarnés
Joan Soler
Eduard Montanya
spellingShingle Marta Montolio
Noèlia Téllez
Montserrat Biarnés
Joan Soler
Eduard Montanya
Short-Term Culture with the Caspase Inhibitor z-VAD.fmk Reduces Beta Cell Apoptosis in Transplanted Islets and Improves the Metabolic Outcome of the Graft
Cell Transplantation
author_facet Marta Montolio
Noèlia Téllez
Montserrat Biarnés
Joan Soler
Eduard Montanya
author_sort Marta Montolio
title Short-Term Culture with the Caspase Inhibitor z-VAD.fmk Reduces Beta Cell Apoptosis in Transplanted Islets and Improves the Metabolic Outcome of the Graft
title_short Short-Term Culture with the Caspase Inhibitor z-VAD.fmk Reduces Beta Cell Apoptosis in Transplanted Islets and Improves the Metabolic Outcome of the Graft
title_full Short-Term Culture with the Caspase Inhibitor z-VAD.fmk Reduces Beta Cell Apoptosis in Transplanted Islets and Improves the Metabolic Outcome of the Graft
title_fullStr Short-Term Culture with the Caspase Inhibitor z-VAD.fmk Reduces Beta Cell Apoptosis in Transplanted Islets and Improves the Metabolic Outcome of the Graft
title_full_unstemmed Short-Term Culture with the Caspase Inhibitor z-VAD.fmk Reduces Beta Cell Apoptosis in Transplanted Islets and Improves the Metabolic Outcome of the Graft
title_sort short-term culture with the caspase inhibitor z-vad.fmk reduces beta cell apoptosis in transplanted islets and improves the metabolic outcome of the graft
publisher SAGE Publishing
series Cell Transplantation
issn 0963-6897
1555-3892
publishDate 2005-01-01
description In the initial days after transplantation islets are particularly vulnerable and show increased apoptosis and necrosis. We have studied the effects of caspase inhibition on this early beta cell death in syngeneically transplanted islets. Streptozotocin-diabetic C57BL/6 mice were transplanted with 150 syngeneic islets, an insufficient mass to restore normoglycemia, preincubated with or without the pan-caspase inhibitor z-VAD. fmk 2 h before transplantation. Beta cell apoptosis was increased in control islets on day 3 after transplantation (0.28 ± 0.02%) compared with freshly isolated islets (0.08 ± 0.02%, p< 0.001), and was partially reduced in transplanted islets preincubated with z-VAD.fmk 200 μM (0.14 ± 0.02%, p = 0.003) or with z-VAD.fmk 500 μM (0.17 ± 0.01%, p = 0.012), but not with a lower z-VAD.fmk (100 μM) concentration. Diabetic mice transplanted with islets preincubated with z-VAD.fmk 500 μM showed an improved metabolic evolution compared with control and z-VAD.fmk 200 μM groups. The z-VAD.fmk 500 μM group showed an overall lower blood glucose after transplantation (p = 0.02), and at the end of the study blood glucose values were reduced compared with transplantation day (15.7 ± 3.6 vs. 32.5 ± 0.5 mmol/L, p = 0.001). In contrast, blood glucose was not significantly changed in control and z-VAD.fmk 200 μM groups. Four weeks after transplantation beta cell mass was higher in z-VAD.fmk 500 μM group (0.15 ± 0.02 mg) than in the control group (0.10 ± 0.02 mg) (p = 0.043). In summary, the treatment of freshly isolated islets with the caspase inhibitor z-VAD.fmk reduced the subsequent apoptosis of the islets once they were transplanted and improved the outcome of the graft.
url https://doi.org/10.3727/000000005783983269
work_keys_str_mv AT martamontolio shorttermculturewiththecaspaseinhibitorzvadfmkreducesbetacellapoptosisintransplantedisletsandimprovesthemetabolicoutcomeofthegraft
AT noeliatellez shorttermculturewiththecaspaseinhibitorzvadfmkreducesbetacellapoptosisintransplantedisletsandimprovesthemetabolicoutcomeofthegraft
AT montserratbiarnes shorttermculturewiththecaspaseinhibitorzvadfmkreducesbetacellapoptosisintransplantedisletsandimprovesthemetabolicoutcomeofthegraft
AT joansoler shorttermculturewiththecaspaseinhibitorzvadfmkreducesbetacellapoptosisintransplantedisletsandimprovesthemetabolicoutcomeofthegraft
AT eduardmontanya shorttermculturewiththecaspaseinhibitorzvadfmkreducesbetacellapoptosisintransplantedisletsandimprovesthemetabolicoutcomeofthegraft
_version_ 1724507994231668736